Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells.

In ovarian carcinoma cells, the combination of interferon-gamma (IFN-gamma) and cisplatin (cDDP) has been reported to result in a synergistic amplification of antiproliferative activity. To assess whether IFN-gamma may also prevent the occurrence of cisplatin resistance, the human ovarian carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Marth, C., Widschwendter, M., Kaern, J., Jørgensen, N. P., Windbichler, G., Zeimet, A. G., Tropé, C., Daxenbichler, G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228156/
https://www.ncbi.nlm.nih.gov/pubmed/9374379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228156/
https://www.ncbi.nlm.nih.gov/pubmed/9374379

Ejemplares similares